Dr. Namrata Vijayvergia provided an excellent discussion of the importance of Precision Promise, highlighting the numerous innovations incorporated in the study, comparing the Bayesian design to a ...

The words, "What you touch, you change. What you change, changes you," perfectly capture the essence of "Nalini", an exhibition by French-Brazilian artist and printmaker Julia Lebrao Sendra.

In her discussion of the ACCELERATE trial, Namrata Vijayvergia, MD, of the Fox Chase Cancer Center, Philadelphia, who was not involved in the study, praised the researchers for conducting a ...

A multicenter, prospective phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to anti-EGFR agents (HGCSG1801): Updated analyses. This is an ...

Efficacy and safety of surufatinib in unresectable or metastatic grade 3 pancreatic neuroendocrine tumors (NET G3): Real-world analysis. Phase II study of mFOLFIRINOX efficacy as first and subsequent ...

For the revered artist Nalini Malani, art has been intertwined in her life since her 20s, with written words creating space for experimental form of art. At the penultimate session, ‘You Can’t ...